Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland (Q84800951)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21857091%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21857091%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

1 reference

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21857091%20AND%20SRC:MED&resulttype=core&format=json

Malgorzata Zwolinska-Wcislo

11 February 2020

series ordinal

4

object named as

Małgorzata Zwolińska-Wcisło

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21857091%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

5

Alicja Budak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21857091%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Izabela Wojtas-Bonior

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21857091%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Edward Sito

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21857091%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21857091%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

published in

Pharmacological Reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21857091%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21857091%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21857091%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

799-807

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21857091%20AND%20SRC:MED&resulttype=core&format=json

Causal role of Helicobacter pylori infection in gastric cancer

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Antimicrobial resistance and characterization of Helicobacter pylori strains isolated from Mexican adults with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Third-line rescue therapy for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Helicobacter pylori-related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

1 reference

7 January 2021

Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Antibiotic resistance in Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

H pylori antibiotic resistance: prevalence, importance, and advances in testing

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

High eradication rates of Helicobacter pylori with a new sequential treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970592-8

7 January 2021

10.1016/S1734-1140(11)70592-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21857091%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference